147 related articles for article (PubMed ID: 1592346)
21. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Mol MJ; Stuyt PM; Stalenhoef AF
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
[TBL] [Abstract][Full Text] [Related]
24. Effects of lovastatin and dietary cholesterol on bile acid kinetics and bile lipid composition in healthy male subjects.
Duane WC
J Lipid Res; 1994 Mar; 35(3):501-9. PubMed ID: 8014585
[TBL] [Abstract][Full Text] [Related]
25. [Simvastatin in the treatment of hypercholesterolemia in the aged. An epidemiological and clinical study].
Tamburrini LR
Minerva Med; 1992 Jun; 83(6):347-53. PubMed ID: 1630695
[TBL] [Abstract][Full Text] [Related]
26. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
27. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
Pernigotti L; Bo M; Poli L; Zanocchi M; Fiandra U; Pedrazzini V; Fabris F
Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
[TBL] [Abstract][Full Text] [Related]
29. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
[TBL] [Abstract][Full Text] [Related]
30. [Effects and side effects of a 1-year treatment of primary hypercholesterolemia with simvastatin].
Brocard JJ; Keller U; Oberhänsli A; Riesen WF
Schweiz Med Wochenschr; 1991 Jun; 121(26):977-83. PubMed ID: 1862314
[TBL] [Abstract][Full Text] [Related]
31. Lovastatin alters biliary lipid composition and dissolves gallstones: a long-term study in prairie dogs.
Abedin MZ; Narins SC; Park EH; Smith PR; Kirkwood KS
Dig Dis Sci; 2002 Oct; 47(10):2192-210. PubMed ID: 12395892
[TBL] [Abstract][Full Text] [Related]
32. [Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial].
Cabezas Gelabert R
Rev Clin Esp; 2004 Dec; 204(12):632-5. PubMed ID: 15710069
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous determination of plasma mevalonate and 7alpha-hydroxy-4-cholesten-3-one levels in hyperlipoproteinemia: convenient indices for estimating hepatic defects of cholesterol and bile acid syntheses and biliary cholesterol supersaturation.
Shoda J; Miyamoto J; Kano M; Ikegami T; Matsuzaki Y; Tanaka N; Osuga T; Miyazaki H
Hepatology; 1997 Jan; 25(1):18-26. PubMed ID: 8985259
[TBL] [Abstract][Full Text] [Related]
34. Reductase inhibitor therapy of hypercholesterolemia.
Kreisberg RA
Trans Am Clin Climatol Assoc; 1991; 102():153-63; discussion 163-5. PubMed ID: 2130558
[No Abstract] [Full Text] [Related]
35. Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
Illingworth DR; Bacon S
Am J Cardiol; 1987 Oct; 60(12):33G-42G. PubMed ID: 3314447
[TBL] [Abstract][Full Text] [Related]
36. Effects of fasting on bile acid metabolism and biliary lipid composition in man.
Duane WC; Ginsberg RL; Bennion LJ
J Lipid Res; 1976 May; 17(3):211-9. PubMed ID: 932555
[TBL] [Abstract][Full Text] [Related]
37. Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.
Kamisako T; Adachi Y
Am J Gastroenterol; 1995 Jul; 90(7):1187-8. PubMed ID: 7611234
[No Abstract] [Full Text] [Related]
38. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
Simons LA
Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
[TBL] [Abstract][Full Text] [Related]
39. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
[TBL] [Abstract][Full Text] [Related]
40. Improvement in the regulation of cellular cholesterologenesis in diabetes: the effect of reduction in serum cholesterol by simvastatin.
Owens D; Stinson J; Collins P; Johnson A; Tomkin GH
Diabet Med; 1991; 8(2):151-6. PubMed ID: 1827401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
